[Combined use of terrilytin, sodium salicylate and heparin for the purpose of regulating hemostasis].
D000681:Amylases / Q000494:pharmacology*; D000818:Animals; D004338:Drug Combinations / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006487:Hemostasis / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology*; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011817:Rabbits; D012980:Sodium Salicylate / Q000494:pharmacology*; D013997:Time Factors
D004338:Drug Combinations; D005343:Fibrinolytic Agents; C009402:amylase, phosphates, proteases drug combinations; D006493:Heparin; D000681:Amylases; D010447:Peptide Hydrolases; D012980:Sodium Salicylate
Kompleksnoe primenenie terrilitina, salitsilata natriia i geparina v tseliakh reguliatsii gemostaza.